Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.

MIRM

Rankning i aktier #3225
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Aktiekurs
$85.12
Senast synkroniserad: 2026-10-20
Marknadsvärde
$5.53B
Förändring (1 dag)
3.50%
Förändring (1 år)
23.39%
Land
US
Handel Mirum Pharmaceuticals, Inc. (MIRM)

Kategori

Healthcare
Historik för aktiesplit för Mirum Pharmaceuticals, Inc. (MIRM)
Aktien Mirum Pharmaceuticals, Inc. (symbol: MIRM) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En MIRM-aktie köpt före Oct 21, 2026 motsvarar nu 0 MIRM-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL